Skip to main content

Fonds Cauris Croissance II

Equity : October 2010

BIO has invested € 5 M in equity in Fonds Cauris Croissance II, a private equity fund dedicated to SMEs in West Africa.

Amount

€ 5,000,000.00

Type of investment

Equity

Development impacts

  • Local economic growth

Beneficiary locations

Africa: Benin, Burkina Faso, Cameroon, Côte d'Ivoire, Ghana, Guinea, Mali, Niger, Senegal, Togo

Investment field

Investment Companies & Funds

Activity

SME Fund

Organisation

Fonds Cauris Croissance II

Domicile

Mauritius

Fonds Cauris Croissance II was launched in 2010. It focuses on companies with a regional development strategy and covers West Africa with the exception of Nigeria. Fonds Cauris Croissance II is the third fund managed by the Cauris Management team.

Development impacts

  • Local economic growth

    Effects at investee level: access to long-term financing for SMEs:
    The Fund is targeting SMEs in West-Africa to provide them with (i) long term capital, (ii) cross-competencies and (iii) access to new markets. There have been only few private equity groups that have been active in this field.

Made possible through this investment

Thanks to the direct funding from BIO, the following second-line investments have been made possible.

Atlantic Business International / Banque Atlantique

Benin, Burkina Faso, Côte d'Ivoire, Mali, Niger, Senegal, Togo

Banque Atlantique is a West African financial services conglomerate with subsidiaries in Benin, Burkina Faso, Côte d’Ivoire, Mali, Niger, Senegal and Togo.

Africa West Industries

Côte d'Ivoire

Africa West Industries (AWI) is a Cote d'Ivoire-based company which produces soap bars and soap pellets. Products are marketed within the West African market.

Axxend Corporation

Cameroon, Côte d'Ivoire, Ghana, Guinea, Senegal

Axxend Corporation (Axxend) is a business technology services provider, dedicated to using the Microsoft platform and SAP technologies to assist enterprises achieve higher efficiency and profitable growth. The company has operating subsidiaries in Senegal, Cote d’Ivoire, Ghana and Cameroon.

Cipharm

Côte d'Ivoire

CIPHARM is the Ivorian leader in pharmaceutical production, present for more than 25 years in the production of generic drugs (dry form, powder and syrup), own brand or licensed, distributed in a dozen countries in West and Central Africa.

SGH SA

Benin, Burkina Faso, Côte d'Ivoire, Guinea, Mali

SGH is Azalaï Hotel Group's Malian subsidiary which operates 4 hotels in Bamako: Hotel Salam, Grand Hotel, Hotel Nord-Sud and Hotel Dunia.

Vipnet

Côte d'Ivoire

Vipnet is a Cote d’Ivoire-based company incorporated in 1999 and providing interconnection, internet (B2B and B2C) and alternative telephony services (international communications through internet VoIP, call termination, etc.).

View more of our investments in this region

Société de Microcrédits Congolais

5,000,000.00

  Democratic Republic of Congo

  01/04/2026

Enterprises

Orchidia Pharmaceutical Industries

8,100,000.00

  Egypt

  01/02/2026

  Equity

Enterprises

Limbua Group

 141,025.00

  Kenya

  01/02/2026

  Subsidy

Investment Companies & Funds

Kampani

 2,000,000.00

  29/01/2026

  Equity

Financial Institutions

Vital Finance

 3,000,000.00

  Benin

  13/01/2026

  Debt

Investment Companies & Funds

Adenia Entrepreneurial Fund

15,000,000.00

  01/01/2026

  Equity

Infrastructure

Bandwidth and Cloud Services

15,000,000.00

  Democratic Republic of Congo, Malawi, Mozambique, Zambia, Zimbabwe

  01/01/2026

  Debt

Infrastructure

Sawa Energy

 29,500.00

  Uganda

  18/12/2025

  Subsidy

Enterprises

Biophyto

 2,750,000.00

  Benin

  01/12/2025

  Debt